Новости/аналитика

07.07.2020

Мнение

Why in Canada of medical crisis cannabis crisis

Most of the built production facilities ...

детально »

06.07.2020

Мнение

According to EUMCA Chair, increasing THC levels in products jeopardizes patient safety

The same products, made from the same varieties of hemp, even using the same methods ...

детально »

03.07.2020

Технологии

Hemp cosmetics company from Colombia will supply cannabinoid cosmetics to Spain

A deal has been concluded under which the "Kuida CBD" line of cosmetics will have to be sold in more than ...

детально »

02.07.2020

Технологии

Why urban transport of French cities will ride on hemp

Gasification project for the depressed agricultural region of France, as well as the production of energy ...

детально »

01.07.2020

Мнение

Hemp raw materials - the future of industrial packaging

Studies of individual consulting companies indicate that by 2030, up to 40% of the plastics industry will use plant components as raw materials, and a significant part of them will be made from hemp raw materials. ...

детально »

30.06.2020

Проблемы отрасли

Only 6% of hemp-based pharmaceuticals allowed in Denmark

This kind of statistics allows us to assert ...

детально »

29.06.2020

Технологии

Cannabis Investment Prospects

There is already a clear need for non-psychoactive varieties in the flower export market. ...

детально »

26.06.2020

Мнение

Canadian-Spanish Alliance Launches Cannabigerol on Maple Leaf Countries

If foreign companies focus on the extraction of specific cannabinoids ...

детально »

25.06.2020

Мнение

Cannabinoids and coronavirus

Cannabidiol is a reasonable candidate for study in preclinical coronavirus models. We are very far from the level of evidence needed to consider the use of cannabinoids as pharmacotherapy for viral diseases, but the continuing high interest in cannabinoids as medicines presents an important opportunity for clinicians. ...

детально »

24.06.2020

Законодательство